Are you up to date with the most recent developments in B-cell depletion therapy? In this live symposium, expert faculty will illustrate the role of B cells in the immunopathology of autoimmune diseases such as Sjögren disease, systemic lupus erythematosus, and systemic sclerosis and will discuss emerging B-cell depleting therapies that are showing promise for these diseases. Their mechanism of action (MOA) and key clinical data will be addressed and implications for future clinical practice will be explored.
Course Director/Chair
Edward Vital, PhD, FRCP
Associate Professor
University of Leeds
Leeds, UK
Panelist
Raphaèle Seror, MD, PhD
Professor
PU-PH University Hospitals of Paris-Sud (Bicêtre)
Le Kremlin-Bicêtre, Île-de-France, France
Panelist
Georg Schett, MD
Professor
Chair of Internal Medicine III
Universitätsklinikum Erlangen
Friedrich-Alexander Universität
Erlangen-Nürnberg, Germany
18:30 TZ
18:40 TZ
19:25 TZ
19:30 TZ
Carrer de l'Alumini, 08908, Barcelona, Spain
Room Name: Session Room 6.1